IHA Hematology Oncology Consultants-Ann Arbor — Ypsilanti, Michigan

IHA Hematology Oncology Consultants-Ann Arbor is a clinical research site located in Ypsilanti, Michigan, United States 48197.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

IHA Hematology Oncology Consultants-Ann Arbor has participated in 48 clinical trials with 15 currently active.

Therapeutic areas: Myelodysplastic Syndromes (MDS), Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma.

Sponsors: National Heart, Lung, and Blood Institute (NHLBI), GOG Foundation, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ypsilanti

Browse all research sites in Michigan · View every site in Ypsilanti

• Saint Joseph Mercy Health System, St. Joseph Mercy [Hospital] Ann Arbor, Cardiac Catheterization Laboratory
• Duplicate_St. Joseph Mercy Hospital /ID# 144143
• St. Joseph Mercy Hospital /ID# 135875
• Ypsilanti Health Center University of Michigan Health Michigan Medicine
• Saint Joseph Mercy Ann Arbor Hospital
• St. Joseph Mercy Ann Arbor Hospital
• Eastern Michigan University Health Services
• St. Joseph Mercy Hospital Cancer Care Center
• Trinity Health Ann Arbor Hospital - Michigan Heart
• Saint Joseph Mercy Hospital Outpatient Laboratory
• University of Michigan-Ypsilanti
• Trinity Health Ann Arbor Hospital

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IHA Hematology Oncology Consultants-Ann Arbor?

IHA Hematology Oncology Consultants-Ann Arbor has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IHA Hematology Oncology Consultants-Ann Arbor conducted?

IHA Hematology Oncology Consultants-Ann Arbor has 48 clinical trials on record, with 15 currently active. Their work covers Myelodysplastic Syndromes (MDS), Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma.

Is IHA Hematology Oncology Consultants-Ann Arbor accredited by Crixeo Clinical Trials?

IHA Hematology Oncology Consultants-Ann Arbor has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IHA Hematology Oncology Consultants-Ann Arbor?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.